Skip to content

Presepsin: Evaluation of a Novel marker for early diagnosis of Sepsis

Evaluation of Diagnostic Accuracy of Novel biomarker Presepsin compared to Procalcitonin in patients with Suspected Sepsis coming to Emergency Department - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/08/072982
Enrollment
92
Registered
2024-08-27
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A419- Sepsis, unspecified organism

Interventions

Control Intervention1: NIL: NIL

Sponsors

John Benny
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients above 18 years with suspected sepsis presenting to Emergency Medicine Department based on 1. Clinicians suspicion of sepsis 2. A known focus of sepsis 3. Signs and symptoms suggestive of sepsis 4. High risk of sepsis

Exclusion criteria

Exclusion criteria: 1. Immuno-compromised 2. Malignancy

Design outcomes

Primary

MeasureTime frame
Primary : Evaluation of accuracy of the Novel biomarker Presepsin in detecting sepsis among patients presenting to the Emergency Department with features suggestive of sepsis using Blood Culture results as standard.Timepoint: Blood sample for Presepsin levels will be collected at admission and compared against Blood Culture report which will be available at 48 hours.

Secondary

MeasureTime frame
Comparison of the efficacy of Presepsin & Procalcitonin in detecting suspected sepsis among patients presenting to Emergency Department with features suggestive of sepsisTimepoint: Blood samples for Presepsin & Procalcitonin levels will be collected at admission & compared against each other & with the Blood Culture report which will be available at 48 hours

Countries

India

Contacts

Public ContactMadhu Srinivasarangan

JSS Medical College and Hospital,JSS AHER

brindabasavaraju@jssuni.edu.in9844327471

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026